COVID-19 Antibody Therapeutics Tracker

Legacy Manually Cleaned

The last update will be made in Aug. 1, 2021, after which, we will no longer maintain this dataset.

About this dataset

As the COVID-19 pandemic is the global healthcare crisis, scientists worldwide are collaborating to prevent or treat COVID-19. Antibody therapeutics hold enormous promise for treatment of COVID-19. Chinese Antibody Society is collaborating with our partner The Antibody Society to track the antibody-based therapeutics targeting COVID-19, to contribute our expertise to the globally joint efforts against the pandemic. In connection with the collaboration, The Antibody Society has published a “Coronavirus in the Crosshairs” series of articles addressing different aspects of therapeutics against COVID-19, and is continuous publishing new information and analysis. This tracker will be updated daily with the latest in developments for antibody therapeutics. If you notice an issue with this data or wish to submit an update, please contact us by email: Management@chineseantibody.org

References

This dataset has been described in the following mansucript. You are requested to cite the this article when you use the COVID-19 Antibody Therapeutics Tracker” from our paper:

  • Lifei Yang, Weihan Liu, Xin Yu, Meng Wu, Janice M Reichert, Mitchell Ho, COVID-19 Antibody Therapeutics Tracker: A Global Online Database of Antibody Therapeutics for the Prevention and Treatment of COVID-19, Antibody Therapeutics
  • Stats at a Glance

    217

    Total Entries

    62

    Targets under investigation

    133 programs targeting S protein

    2

    Antibodies approved for treatment

    217 antibodies in phase 1 to 3

    203

    or more research groups and/or institutions

    52 or more countries

    Data Table

    ID Name Target Format Status Organization Country Descriptions Derivation Discovery platform
    1 REGN-COV2 (REGN10933/Casirivimab + REGN10987/Imdevimab) SARS-CoV-2 S protein mAb Phase 3 Regeneron/NIAID USA Humanized mouse or Human unknown
    2 Bamlanivimab (LY3819253, LY-CoV555) SARS-CoV-2 S protein mAb Phase 3 AbCellera/Eli Lilly/NIH Canada/USA Human Single B cell cloning
    3 Sotrovimab (VIR-7831/GSK4182136) SARS-CoV-2 S protein mAb Phase 3 Vir biotechnology/GSK USA/UK Human Single B cell cloning
    4 AZD7442 (AZD8895/Tixagevimab + AZD1061/Cilgavimab) SARS-CoV-2 S protein mAb Phase 3 AstraZeneca/Vanderbilt University Medical Center/DARPA/BARDA UK/USA Human Single B cell cloning
    5 Regdanvimab (CT-P59) SARS-CoV-2 S protein mAb Phase 3 Celltrion South Korea Human unknown
    6 TY027 SARS-CoV-2 S protein mAb Phase 3 Tychan Singapore unknown unknown
    7 BRII-196 + BRII-198 SARS-CoV-2 S protein mAb Phase 3 Brii Biosciences/NIAID USA unknown unknown
    8 DXP-593 SARS-CoV-2 S protein mAb Phase 2 Beigene/Singlomics Biopharmaceuticals/Peking University etc China Human Single B cell cloning
    9 Etesevimab (JS016, LY-CoV016, LY3832479) SARS-CoV-2 S protein mAb Phase 2 Junshi Biosciences/Institute of Microbiology, Chinese Academy of Sciences/Eli Lilly China/USA Human Single B cell cloning
    10 DZIF-10c, BI 767551 SARS-CoV-2 S protein mAb Phase 2 University of Cologne/Boehringer Ingelheim Germany Human Single B cell cloning
    11 COVI-AMG (STI-2020) SARS-CoV-2 S protein mAb Phase 2 Sorrento Therapeutics USA unknown unknown
    12 COR-101 SARS-CoV-2 S protein mAb Phase 2 YUMAB /CORAT therapeutics Germany Human unknown
    13 STI-1499/COVI-SHIELD SARS-CoV-2 S protein mAb Phase 1 Sorrento/Mount Sinai Health System USA unknown unknown
    14 BRII-196 SARS-CoV-2 S protein mAb Phase 1 Brii Bio/TSB Therapeutics/Tsinghua University China/USA Human Single B cell cloning
    15 BRII-198 SARS-CoV-2 S protein mAb Phase 1 Brii Bio/TSB Therapeutics/Tsinghua University China/USA Human Single B cell cloning
    16 SCTA01 SARS-CoV-2 S protein mAb Phase 1 Sinocelltech Ltd/Chinese Academy of Sciences China unknown unknown
    17 MW33 SARS-CoV-2 S protein mAb Phase 1 Mabwell (Shanghai) Bioscience Co., Ltd. China unknown unknown
    18 HFB30132A SARS-CoV-2 S protein mAb Phase 1 HiFiBiO Therapeutics USA unknown unknown
    19 ADM03820 SARS-CoV-2 S protein mAb Phase 1 Ology Bioservices USA unknown unknown
    20 47D11 SARS-CoV-2 S protein mAb Phase 1 Abbvie/Erasmus MC/Harbor BioMed/Utrecht University Netherlands/China/USA Humanized mouse unknown
    21 HLX70 SARS-CoV-2 S protein mAb Phase 1 Hengenix Biotech Inc China unknown unknown
    22 DXP-604 SARS-CoV-2 S protein mAb Phase 1 BeiGene/Singlomics China unknown unknown
    23 Anti-SARS-CoV-2 mAb SARS-CoV-2 S protein mAb Phase 1 Stanford University USA unknown unknown
    24 VIR-7832 SARS-CoV-2 S protein mAb Preclinical Vir biotechnology/GSK USA/UK Human Single B cell cloning
    25 IDB003 SARS-CoV-2 S protein mAb Preclinical Idbiologics Inc. USA unknown unknown
    26 Anti-SARS-CoV-2 mAb SARS-CoV-2 S protein mAb Preclinical Adimab/Adagio Therapeutics USA unknown unknown
    27 Anti-SARS-CoV-2 mAb SARS-CoV-2 S protein mAb Preclinical Shanghai henlius biotech/Sanyou Biopharmaceuticals/Shanghai ZJ Bio-Tech China Human Phage display
    28 Anti-SARS-CoV-2 mAb by non-viral gene delivery platform SARS-CoV-2 S protein mAb Preclinical Vir Biotechnology, Inc/ Generation Bio USA unknown unknown
    29 Anti-SARS-CoV-2 mAb SARS-CoV-2 S protein mAb Preclinical Medicago/Laval University Canada unknown unknown
    30 Anti-SARS-CoV-2 mAb SARS-CoV-2 S protein mAb Preclinical AvantGen USA unknown Yeast display
    31 Anti-SARS-CoV-2 mAb SARS-CoV-2 S protein mAb Preclinical Innovent Biologics China Human unknown
    32 Anti-SARS-CoV-2 mAb SARS-CoV-2 S protein mAb Preclinical Ablexis, LLC, AlivaMab Discovery Services, LLC and Berkeley Lights, Inc USA unknown unknown
    33 Anti-SARS-CoV-2 mAb SARS-CoV-2 S protein mAb Preclinical Ligand USA unknown unknown
    34 Anti-SARS-CoV-2 mAb SARS-CoV-2 S protein mAb Preclinical Institut Pasteur France unknown unknown
    35 Anti-SARS-CoV-2 mAb SARS-CoV-2 S protein mAb Preclinical ThermoGenesis Holdings, Inc., ImmuneCyte/Zhejiang University School of Medicine/ East China Normal University USA Human unknown
    36 Anti-SARS-CoV-2 mAb SARS-CoV-2 S protein mAb Preclinical Specifica USA unknown unknown
    37 Anti-SARS-CoV-2 mAb SARS-CoV-2 S protein mAb Preclinical GenScript ProBio China unknown unknown
    38 MTX-COVAB SARS-CoV-2 S protein mAb Preclinical Memo Therapeutics AG Switzerland unknown unknown
    39 Anti-SARS-CoV-2 mAb SARS-CoV-2 S protein mAb Preclinical Virna Therapeutics /University of Toronto Canada unknown unknown
    40 Anti-SARS-CoV-2 mAbs SARS-CoV-2 S protein mAb Preclinical Atreca/BeiGene/IGM Biosciences USA/China unknown unknown
    41 Anti-SARS-CoV-2 program SARS-CoV-2 mAb Preclinical Xbiotech USA Human unknown
    42 MP0420 SARS-CoV-2 S protein DARPin Preclinical Molecular Partners/Novartis Switzerland/US unknown Phage display
    43 MP0423 SARS-CoV-2 S protein DARPin Preclinical Molecular Partners/Novartis Switzerland/US unknown Phage display
    44 VHH72-Fc SARS-CoV-2 S protein single-domain Ab Preclinical ExeVir Bio/The University of Texas at Austin/Ghent University/VIB USA/Belgium llama Phage display
    45 Nb11-59 SARS-CoV-2 S protein single-domain Ab Preclinical Shanghai Novamab Biopharmaceuticals Co., Ltd China camel Phage display
    46 Anti-SARS-CoV-2 VNAR antibodies SARS-CoV-2 S protein single-domain Ab Preclinical Ossianix UK unknown Phage display
    47 Ab8 SARS-CoV-2 S protein single-domain Ab Preclinical University of Pittsburgh School of Medicine/Abound Bio/University of North Carolina/University of Texas Medical Branch/University of British Columbia/University of Saskatchewan USA unknown unknown
    48 SI-F019 SARS-CoV-2 S protein fusion protein Preclinical Systimmune USA unknown unknown
    49 89C8-ACE2 SARS-CoV-2 S protein fusion protein Preclinical Biotheus Inc. China unknown unknown
    50 STI-2020dna SARS-CoV-2 S protein mAb (nucleic acid-encoded) Preclinical Sorrento Therapeutics USA unknown unknown
    51 STI-2020,COVI-AMG SARS-CoV-2 S protein mAb Preclinical Sorrento Therapeutics USA unknown unknown
    52 Ab1+Ab5 SARS-CoV-2 S protein mAb Preclinical Biocytogen/Eucure Biopharma USA unknown unknown
    53 Anti-SARS-CoV-2 mAb SARS-CoV-2 S protein mAb Preclinical Achilles Vaccines Italy unknown unknown
    54 NOVOAB-20 SARS-CoV-2 S protein mAb Preclinical NovoAb Bioanalytics Canada unknown unknown
    55 Anti-SARS-CoV-2 mAb SARS-CoV-2 S protein mAb Preclinical Y Biologics/Genexine South Korea unknown unknown
    56 Anti-SARS-CoV-2 mAb SARS-CoV-2 S protein mAb Preclinical Jecho Biopharmaceuticals Co., Ltd., Jecho Labs China/USA unknown unknown
    57 Anti-SARS-CoV-2 mAb SARS-CoV-2 S protein mAb Preclinical Kaneka Corporation Japan unknown unknown
    58 ABP-300 (aka MW05), MW07 SARS-CoV-2 S protein mAb Preclinical Abpro/Mabwell USA unknown unknown
    59 DNA-encoded monoclonal antibody SARS-CoV-2 S protein mAb (nucleic acid-encoded) Preclinical INOVIO/The Wistar Institute/AstraZeneca/the University of Pennsylvania, and Indiana University USA unknown unknown
    60 Anti-SARS-CoV-2 mAb SARS-CoV-2 S protein mAb Preclinical Eureka Therapeutics USA unknown unknown
    61 ACmab1 (COVIMAX) SARS-CoV-2 S protein mAb Preclinical AXON Neuroscience CYPRUS unknown unknown
    62 DNP-019 Undisclosed mAb Preclinical DiNonA, Inc. South Korea unknown unknown
    63 AR-711 SARS-CoV-2 S protein mAb Preclinical Aridis Pharmaceuticals, Inc. USA unknown unknown
    64 JMB2020 SARS-CoV-2 mAb Preclinical Jemincare China unknown unknown
    65 Anti-SARS-CoV2 mAb SARS-CoV-2 S protein Multi-specific Ab Preclinical Ab Studio Inc. USA unknown unknown
    66 Anti-SARS-CoV2 mAb SARS-CoV-2 S protein mAb Preclinical Halberd Corporation / Arizona State University USA unknown unknown
    67 Anti-SARS-CoV-2 bispecific mAb SARS-CoV-2 S protein mAb Preclinical Sorrento Therapeutics USA unknown unknown
    68 Anti-SARS-CoV-2 mAb SARS-CoV-2 S protein mAb Discovery Evotec SE USA unknown unknown
    69 Anti-SARS-CoV-2 mAb SARS-CoV-2 S protein mAb Discovery Abbvie/Harvard University USA unknown unknown
    70 Anti-SARS-CoV-2 mAb SARS-CoV-2 S protein mAb Discovery MassBiologics/UMass Medical School USA unknown unknown
    71 Anti-SARS-CoV-2 mAb SARS-CoV-2 S protein mAb Discovery Icosagen Estonia unknown unknown
    72 Anti-SARS-CoV-2 mAb SARS-CoV-2 S protein mAb Discovery Hemogenyx/Immugenyx USA/UK unknown unknown
    73 Anti-SARS-CoV-2 mAbs SARS-CoV-2 S protein mAb Discovery Mount Sinai Health System USA/China unknown unknown
    74 Anti-SARS-CoV-2 mAb SARS-CoV-2 S protein mAb Discovery AbCellera Canada unknown unknown
    75 Pan-coronavirus mAb SARS-CoV-2 S protein mAb Discovery Celltrion South Korea unknown unknown
    76 Anti-SARS-CoV-2 mAb SARS-CoV-2 S protein mAb Discovery YUMAB /Boehringer Ingelheim Germany unknown unknown
    77 Anti-SARS-CoV-2 mAb SARS-CoV-2 S protein mAb Discovery Aridis Pharmaceuticals, Inc. USA unknown unknown
    78 Anti-SARS-CoV-2 program SARS-CoV-2 S protein mAb Discovery Amgen and Adaptive Biotechnologies USA Human Single B cell cloning
    79 Anti-SARS-CoV-2 mAb SARS-CoV-2 S protein mAb Discovery Chugai/A*STAR Japan/Singapore unknown unknown
    80 Anti-SARS-CoV-2 mAb SARS-CoV-2 S protein mAb Discovery Columbia University/Brii Biosciences USA unknown unknown
    81 Anti-SARS-CoV-2 mAb SARS-CoV-2 S protein mAb Discovery Coronavirus Immunotherapy Consortium; multiple partners, including Carterra USA unknown unknown
    82 Anti-SARS-CoV-2 mAb SARS-CoV-2 S protein mAb Discovery Chelsea and Westminster Hospital, Imperial College London UK unknown unknown
    83 Anti-SARS-CoV-2 mAb SARS-CoV-2 S protein mAb Discovery Centivax/ Distributed Bio USA Human unknown
    84 Anti-SARS-CoV-2 mAb SARS-CoV-2 S protein mAb Discovery Scripps/IAVI USA unknown unknown
    85 Anti-SARS-CoV-2 mAb SARS-CoV-2 S protein mAb Discovery FairJourney Biologics / Iontas Portugal unknown Phage display
    86 Anti-SARS-CoV-2 mAb SARS-CoV-2 S protein mAb Discovery Alliance led by Proteona, including the University Clinic, Heidelberg, Tübingen University Hospital, the German Cancer Research Center (DKFZ), the NMI Natural and Medical Sciences Institute, NUS Enterprise, and 10x Genomics. Germany/USA Human Single B cell cloning
    87 Anti-SARS-CoV-2 program SARS-CoV-2 S protein mAb Discovery International group/Antibody Therapy Against Corona Virus Sweden/Belgium/Italy/Switzerland unknown unknown
    88 Anti-SARS-CoV-2 mAb SARS-CoV-2 S protein mAb Discovery Fusion Antibodies, Queen's Univeristy UK/Canada unknown unknown
    89 Anti-SARS-CoV-2 mAb SARS-CoV-2 S protein mAb Discovery BioDuro LLC USA unknown unknown
    90 Anti-SARS-CoV-2 mAb SARS-CoV-2 S protein mAb Discovery Hemogenyx Pharmaceuticals plc UK Humanized mouse unknown
    91 Anti-SARS-CoV-2 mAb SARS-CoV-2 S protein mAb Discovery Prellis Biologics USA unknown unknown
    92 Anti-SARS-CoV-2 mAb SARS-CoV-2 S protein mAb Discovery Eli Lilly/Chugai USA/Japan unknown unknown
    93 Anti-SARS-CoV-2 mAb SARS-CoV-2 S protein mAb Discovery Integral Molecular USA unknown unknown
    94 Anti-SARS-CoV-2 mAb SARS-CoV-2 S protein mAb Discovery Evotec / Ology Bioservices / DoD Germany/USA unknown unknown
    95 Anti-SARS-CoV-2 mAb SARS-CoV-2 S protein mAb Discovery GC Green Cross South Korea unknown unknown
    96 Anti-SARS-CoV-2 mAb SARS-CoV-2 S protein mAb Discovery Formycon AG Germany unknown unknown
    97 Anti-SARS-CoV-2 mAb SARS-CoV-2 S protein mAb Discovery BriaCell Therapeutics Corp. Canada unknown unknown
    98 Anti-SARS-CoV-2 mAb SARS-CoV-2 S protein mAb Discovery AbClon Inc South Korea unknown unknown
    99 AV103 SARS-CoV-2 S protein mAb Discovery AbClon Inc South Korea unknown unknown
    100 Anti-SARS-CoV-2 mAb SARS-CoV-2 S protein mAb Discovery University of Amsterdam/Sanquin Research Netherlands unknown unknown
    101 IgG1 ab1 SARS-CoV-2 S protein mAb Discovery University of Pittsburgh USA unknown unknown
    102 B38, H4, and other mAbs SARS-CoV-2 S protein mAb Discovery Institute of Microbiology, Chinese Academy of Sciences/Shenzhen Third People’s Hospital/ China Human Single B cell cloning
    103 4A8 SARS-CoV-2 S protein mAb Discovery Academy of Military Medical Sciences/Westlake University/Tsinghua-Peking Joint Center for Life Sciences China Human Single B cell cloning
    104 311mab-31B5, 32D4, and other mAbs SARS-CoV-2 S protein mAb Discovery Third Military Medical University/Chongqing Public Health Medical Center/Chinese Academy of Medical Sciences and Peking Union Medical College China Human Single B cell cloning
    105 414-1 and other mAbs SARS-CoV-2 S protein mAb Discovery Fudan University/Active Motif China Human Single B cell cloning
    106 Anti-SARS mAb SARS-CoV-2 S protein mAb Discovery Massachusetts Consortium on Pathogen Readiness (MassCPR) USA unknown unknown
    107 Anti-SARS-CoV-2 mAb SARS-CoV-2 S protein mAb Discovery Rockefeller University USA unknown unknown
    108 Anti-SARS-CoV-2 mAb SARS-CoV-2 S protein mAb Discovery Israel Institute for Biological Research/Dyadic International, Inc. Israel/USA unknown unknown
    109 Anti-SARS-CoV-2 mAb SARS-CoV-2 S protein mAb Discovery Virotek/AiVie Inc USA unknown unknown
    110 Anti-SARS-CoV-2 mAb SARS-CoV-2 S protein mAb Discovery Affinity Biosciences Pty Ltd China unknown unknown
    111 Anti-SARS-CoV-2 mAb SARS-CoV-2 S protein mAb Discovery Tonix Pharmaceuticals Holding Corp.,/Columbia University USA unknown unknown
    112 Anti-SARS-CoV-2 mAb SARS-CoV-2 S protein mAb Discovery Pyrizon/Medigus Israel unknown unknown
    113 Anti-SARS-CoV-2 mAb SARS-CoV-2 S protein Antibody-Drug Conjugate Discovery Oncoseek Bio Pvt Ltd,/Oncosimis Biotech Pvt Ltd.,/Reagene Biosciences Pvt Ltd.,/IgY Pvt Ltd. India/USA unknown unknown
    114 Anti-SARS-CoV-2 mAb SARS-CoV-2 S protein mAb Discovery Twist Bioscience USA unknown unknown
    115 Anti-SARS-CoV-2 mAb SARS-CoV-2 S protein mAb Discovery Ginkgo Bioworks/Totient USA unknown unknown
    116 Anti-SARS-CoV-2 mAb SARS-CoV-2 S protein mAb (nucleic acid-encoded) Discovery Neurimmune AG / Ethris GmbH Switzerland unknown unknown
    117 Aeronab 6 SARS-CoV-2 S protein single-domain Ab Discovery University of California, San Francisco USA llama unknown
    118 Anti-SARS-CoV-2 mAb SARS-CoV-2 S protein single-domain Ab Discovery IMMUNOPRECISE ANTIBODIES LTD/Talem Therapeutics, EVQLV Canada Llama Phage
    119 rRBD-15 SARS-CoV-2 S protein single-domain Ab Discovery ABLINK Biotech/Chengdu Medical College China Synthetic antibody library Phage display
    120 Anti-SARS-CoV-2 mAb SARS-CoV-2 S protein single-domain Ab Discovery Fudan University China Synthetic antibody library Phage display
    121 Anti-SARS-CoV-2 mAb SARS-CoV-2 S protein single-domain Ab Discovery Chinese Academy of Medical Sciences and Peking Union Medical College China Synthetic antibody library Phage display
    122 Anti-SARS-CoV-2 mAb SARS-CoV-2 S protein single-domain Ab Discovery Beroni Group / Tianjin University China unknown unknown
    123 Anti-SARS-CoV-2 mAb SARS-CoV-2 S protein single-domain Ab Discovery Harvard University USA synthetic antibody library unknown
    124 Anti-SARS-CoV-2 mAb SARS-CoV-2 S protein single-domain Ab Discovery Lumen Bioscience USA unknown unknown
    125 Anti-SARS-CoV-2 sdAb SARS-CoV-2 S protein single-domain Ab Discovery Abcore USA unknown Phage display
    126 Anti-SARS-CoV-2 fusion protein SARS-CoV-2 S protein fusion protein Discovery Cidara Therapeutics, Inc. USA unknown unknown
    127 CMAB020, STI-4920, ACE-MAB SARS-CoV-2 S protein fusion protein Discovery Mabpharm/Sorrento Therapeutics USA/China unknown unknown
    128 STI-4398, COVIDTRAP SARS-CoV-2 S protein fusion protein Discovery Sorrento Therapeutics USA unknown unknown
    129 Anti-SARS-CoV-2 mAb SARS-CoV-2 S protein mAb Discovery Columbia University USA Human unknown
    130 XAV-19 SARS-CoV-2 polyclonal Abs Phase 2 Xenothera, LFB/Nantes University Hospital/BPIfrance France Swine unknown
    131 SAB-185 SARS-CoV-2 S protein polyclonal Abs Phase 1 SAB Biotherapeutics USA Transgenic cow unknown
    132 INOSARS SARS-CoV-2 S protein polyclonal Abs Clinical pending José Fernando Castilleja-Leal, Hospital San Jose Tec de Monterrey Mexico Equine unknown
    133 OstriGen SARS-CoV-2 mAbs SARS-CoV-2 S protein polyclonal Abs Preclinical Ostrich Pharma USA Japan Ostrich unknown
    134 IgY-110 SARS-CoV-2 S protein polyclonal Abs Preclinical IGY Life Sciences/MMS Holdings USA Avian unknown
    135 GIGA-2050 SARS-CoV-2 polyclonal Abs Preclinical GigaGen USA Human unknown
    136 Anti-SARS-CoV-2 mAb SARS-CoV-2 S protein polyclonal Abs Preclinical ThermoGenesis Holdings, Inc., ImmuneCyte USA Human unknown
    137 Anti-SARS-CoV-2 mAb SARS-CoV-2 S protein mAb Discovery Immunome USA unknown unknown
    138 Itolizumab (EQ001, H-T1, T1-h) CD6 mAb Approved Biocon India unknown unknown
    139 Levilimab (BCD-089) IL-6R mAb Approved BIOCAD Russia unknown unknown
    140 Tocilizumab IL-6R mAb Phase 4 Hoffmann-La Roche/multiple sponsors USA/Canada/Denmark/Germany/Italy/Netherlands/Spain/UK/Belgium Mouse unknown
    141 Ravulizumab-cwvz C5 mAb Phase 4 Alexion Pharmaceuticals/Cambridge University Hospitals NHS Foundation Trust USA/UK Mouse unknown
    142 Sarilumab (SAR153191, Kevzara) IL-6R mAb Phase 4 Regeneron/Sanofi/multiple sponsors France Humanized mouse unknown
    143 Siltuximab IL-6 mAb Phase 3 University Hospital, Ghent/A.O. Ospedale Papa Giovanni XXIII USA/Belgium Mouse unknown
    144 Lenzilumab GM-CSF mAb Phase 3 Humanigen USA Human unknown
    145 Canakinumab IL-1β mAb Phase 3 Novartis USA/France/Germany/Italy/UK/Spain/Russia unknown unknown
    146 CD24Fc (SACCOVID) DAMPs, Siglec G/10 fusion protein Phase 3 OncoImmune USA unknown unknown
    147 Olokizumab IL-6 mAb Phase 3 R-Pharm JSC/Cromos Pharma USA unknown unknown
    148 Leronlimab (PRO-140) CCR5 mAb Phase 3 CytoDyn Canada/USA Mouse unknown
    149 Emapalumab (Gamifant) IFN gamma mAb Phase 3 Swedish Orphan Biovitrum Sweden/Italy Human unknown
    150 Bevacizumab VEGF mAb Phase 3 Qilu Hospital of Shandong University/Renmin Hospital of Wuhan University/Ialy Moriggia Pelascini Gravedona Hospital S.p.A/Wuhan University/Jiangbei Union Hospital of Huazhong University of science and technology/Shandong Provincial Chest Hospital USA/China Mouse unknown
    151 IFX-1 (BDB-001) C5a mAb Phase 3 Staidson/InflaRx/Beijing Defengrei Biotechnology China/Germany/Spain unknown unknown
    152 Clazakizumab IL-6 mAb Phase 3 Medical University of Vienna/NYU Langone Health Austria/USA unknown unknown
    153 RPH-104 IL-1 fusion protein Phase 3 R-Pharm JSC, Cromos Pharma USA unknown unknown
    154 Pamrevlumab(FG-3019) Connective tissue growth factor (aka CCN2) mAb Phase 3 FibroGen, Inc. USA unknown unknown
    155 Mavrilimumab GM-CSF receptor mAb Phase 3 Kiniksa Pharmaceuticals/multiple sponsors USA/Italy Human Phage display
    156 UTTR1147A IL-22R fusion protein Phase 2 Genentech USA unknown unknown
    157 F-652 IL-22R fusion protein Phase 2 Generon(Shanghai) Corporation Ltd. China unknown unknown
    158 APG101 CD95 ligand fusion protein Phase 2 Apogenix GmbH Germany unknown unknown
    159 Crizanlizumab P-selectin mAb Phase 2 Johns Hopkins University/Novartis/Socar Research SA/Brigham and Women's Hospital USA unknown unknown
    160 Garadacimab (CSL312) Factor XIIa mAb Phase 2 CSL Behring USA unknown unknown
    161 Infliximab TNF mAb Phase 2 Tufts Medical Center/NIH USA unknown unknown
    162 APN01 SARS-CoV-2 S protein recombinant protein Phase 2 APEIRON Biologics Austria/Denmark/Germany unknown unknown
    163 Otilimab GM-CSF mAb Phase 2 GSK UK unknown unknown
    164 Avdoralimab C5aR mAb Phase 2 Innate Pharma SA France unknown unknown
    165 Zansecimab (LY3127804) Ang-2 mAb Phase 2 Eli Lilly USA unknown unknown
    166 Eculizumab C5 mAb Phase 2 Alexion Pharmaceuticals/Hudson Medical USA/France Mouse unknown
    167 Camrelizumab PD-1 mAb Phase 2 Jiangsu HengRui Medicine/Southeast University/Wuhan Jinyintan Hospital China Mouse unknown
    168 Pembrolizumab PD-1 mAb Phase 2 Medica Scientia Innovation Research (MEDSIR) Spain Humanized unknown
    169 Gimsilumab GM-CSF mAb Phase 2 Roivant Sciences USA Human unknown
    170 Ixekizumab IL-17A mAb Phase 2 Xiangya Hospital of Central South University China Mouse unknown
    171 BMS-986253, HuMax-IL8, HuMax-Inflam/MDX018 IL-8 mAb Phase 2 Bristol-Myers Squibb USA Humanized mouse unknown
    172 Astegolimab IL-33R mAb Phase 2 Genentech USA unknown unknown
    173 Secukinumab (AIN457) IL-17A mAb Phase 2 Lomonosov Moscow State University Medical Research and Educational Center Russia unknown unknown
    174 ATYR1923 Neuropilin-2 mAb Phase 2 aTyr Pharma, Inc. USA unknown unknown
    175 Axatilimab (SNDX-6352) CSF-1R mAb Phase 2 Syndax Pharmaceuticals, Inc USA unknown unknown
    176 NN8765, IPH-2201, NNC141-0100 NKG2A (CD159a) mAb Phase 2 Innate Pharma SA France unknown unknown
    177 CNTO 136 IL-6 mAb Phase 2 Janssen USA unknown unknown
    178 CERC-002 LIGHT mAb Phase 2 Cerecor USA unknown unknown
    179 TJM2 (TJ003234) GM-CSF mAb Phase 2 I-MAB USA/South Korea unknown unknown
    180 IC14 CD14 mAb Phase 2 Implicit Bioscience Australia unknown unknown
    181 Meplazumab CD147 mAb Phase 2 Tang-Du Hospital China Mouse unknown
    182 Risankizumab IL-23 p19 mAb Phase 2 NIH USA unknown unknown
    183 MAS825 TIM-3 mAb Phase 2 Novartis Pharmaceuticals USA unknown unknown
    184 IMP321 (Eftilagimod alpha) Antigen-presenting cells fusion protein Phase 2 Immutep Ltd. (formerly Prima BioMed Ltd) Austrilia unknown unknown
    185 ACT017 (Glenzocimab) Glycoprotein VI platelet mAb Phase 2 Acticor Biotech France unknown unknown
    186 NGM621 Complement C3 mAb Phase 2 NGM Bio USA unknown unknown
    187 Adrecizumab(HAM8101) Adrenomedulin mAb Phase 1 Adrenomed AG USA humanized unknown
    188 CPI-006 CD73 mAb Phase 1 Corvus Pharmaceuticals USA unknown unknown
    189 hzVSFv13 Vimentin mAb Phase 1 ImmuneMed South Korea unknown unknown
    190 Lanadelumab kallikrein mAb Phase 1 Radboud University/Takeda USA unknown unknown
    191 AK119 CD73 mAb Phase 1 Akesobio Australia/New Zealand unknown unknown
    192 Daxdilimab (VBI7734) ILT7 mAb Phase 1 Viela Bio USA unknown unknown
    193 Efineptakin alfa(GX-17) IL-7R recombinant protein Phase 1 NeoImmuneTech USA unknown unknown
    194 Abatacept CD80/CD86 fusion protein Clinical pending BMS USA unknown unknown
    195 TAK-671 Proteases mAb Clinical pending Samsung Bioepis Co.,Ltd.,Takeda South Korea unknown unknown
    196 Narsoplimab(OMS-721) MASP-2 mAb Clinical pending Omeros Corporation USA unknown unknown
    197 Nivolumab PD-1 mAb Clinical pending Centre Leon Berard/Dr Gerry Gin Wai Kwok/Assistance Publique - Hôpitaux de Paris France/China unknown unknown
    198 CSL324 G-CSFR mAb Clinical pending CSL Behring USA unknown unknown
    199 MEDI3506 IL-33 mAb Clinical pending AstraZenaca/UK ACCORD initiative UL unknown unknown
    200 Namilumab (IZN-101) GM-CSF mAb Clinical pending Izana Bioscience/Humanitas Research Hospital UK/Italy Human Phage display
    201 Adalimumab TNF mAb Clinical pending Shanghai Changzheng Hospital/Botnar Research Centre China/UK unknown unknown
    202 CMAB806 IL-6R mAb Clinical pending Jinyu Bio-technology Co Ltd China unknown unknown
    203 IC100 ASC mAb Preclinical ZyVersa Therapeutics, Inc. USA unknown unknown
    204 Anti-IL-1R7 mAb IL-1R7 mAb Preclinical IcanoMAB Germany unknown unknown
    205 NI-0101 TLR4 mAb Preclinical Edesa Biotech/Light Chain Bioscience USA/Switzerland unknown unknown
    206 NI-0801 CXCL10 mAb Preclinical Edesa Biotech/Light Chain Bioscience USA/Switzerland unknown unknown
    207 Pritumumab Vimentin mAb Preclinical Nascent Biotech USA Human unknown
    208 Neutralizing antibody 4-1bb mAb Preclinical Eutilex South Korea unknown unknown
    209 TZLS-501 (NI-1201) IL-6R mAb Preclinical Tiziana Life Sciences/NovImmune USA Human unknown
    210 REGN3048-3051 MERS-CoV mAb Preclinical Regeneron Pharmaceuticals USA Humanized mouse or Human unknown
    211 ALT-100 NAMPT mAb Preclinical Aqualung Therapeutics / Fusion Antibodies USA unknown unknown
    212 Anti-SARS-CoV-2 program SARS-CoV-2, NKp46 Multi-specific Ab Preclinical Cytovia Therapeutics, Inc. USA unknown unknown
    213 radiotherapeutics (uPRITs) Plasminogen Activator Receptor (uPAR) radiotherapeutics (uPRITs) Preclinical Monopar/NorthStar USA unknown unknown
    214 Foralumab CD3 mAb Preclinical Tiziana Life Sciences plc UK unknown unknown
    215 Undisclosed Undisclosed fusion protein Discovery JN Nova Pharma Canada unknown unknown
    216 KSI-501 VEGF/IL-6 Multi-specific Ab Discovery Kodial Sciences Inc. USA unknown unknown
    217 TriKE anti-SARS-CoV-2 CD16/SARS-CoV-2 Multi-specific Ab Discovery GT Biopharma, Inc. USA unknown unknown

    Data Landscape

    Refinement Search

    This section is provided to help you refine search and quickly navigate to the references to the antibodies.

    Target

    Status

    Format

    Country